Low-Grade Appendiceal Mucinous Neoplasm
NCI Definition: A well differentiated mucinous adenocarcinoma that arises from the appendix. It is characterized by slow growth and it is associated with the development of pseudomyxoma peritonei. Unlike the high grade mucinous adenocarcinoma of the appendix, it usually does not spread beyond the peritoneum and it does not metastasize to distant anatomic sites. 
There is 1 clinical trial for low-grade appendiceal mucinous neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains low-grade appendiceal mucinous neoplasm as an inclusion criterion, 1 is phase 2 (1 open).
Nilotinib and paclitaxel are the most common interventions in low-grade appendiceal mucinous neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.